Indian pharmaceutical companies face potential disruptions in the US market due to President Trump's new orders promoting American-made prescription drugs, which could reshape glob...
The Indian pharmaceutical sector faces uncertainty as US trade policies under Trump hint at potential tariffs, despite current exemptions. Companies are urged to diversify markets ...
Indian pharmaceutical stocks slumped after US President Donald Trump threatened to impose tariffs on drug imports, impacting India's significant export market to the US. Key player...
